InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: None

Friday, 01/15/2021 9:33:42 PM

Friday, January 15, 2021 9:33:42 PM

Post# of 403254
What we know:

1) the Bakovic paper re B v C has not been published in any peer review journal so far. So much for peer review, touted by the company, touted by so many here. What happened, folks? Oct 30 date( very late per Leo hype) but nothing since on the publishing front. So it was sort of a scientific, what, exactly? Good enough for a trial, not good enough for publication. Sigh.

Other data from Bakovic is NOT B, it is LL-37 for VEEV. Hey wasn't it B that was supposed to be so great for all those other viruses, per IP PRs???? Scandalous and pathetic misleading speculation by our company and our CEO, IP and Leo. Which leads us to....

2) No grant despite the hype. None. Maybe B has a role for other corona viruses, maybe not. So much grant hype, over and over, and NOTHING ever came of it. A joke played on the shareholders, who have yet to figure it out, apparently.

3)Trial did not start yet, although Leo promised q4 and said trial discussions began 9 months ago in April 2020. Any day now.

Oh yeah, the planned trial is likely to focus on those with widespread disease already, while the drug's main benefit has been reported to be stop of viral spreading.....best wishes, B, you might help, but it'll be a miracle if the human trial recapitulates the lab data. But you all know that, right?

4)People are dying by the thousands, daily, just in the US, despite standard care, and solutions are desperately needed. It is NOT AT ALL CLEAR that B is a solution despite what you may read here. Sticky this for now and and we will meet back here in 60 days and assess the COVID therapeutic world. Cross your fingers and hope that B can play a role and see you in mid March
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News